Sébastien Grosso

1.2k citations
15 papers · 1.0k indexed · h-index 14
Topics
Chronic Myeloid Leukemia Treatments (4 papers)Chronic Lymphocytic Leukemia Research (3 papers)MicroRNA in disease regulation (3 papers)

In The Last Decade

Sébastien Grosso

15 papers receiving 1.0k citations

Peers

Sébastien Grosso
Comparison fields: 5 of 78
  • Molecular Biology 719
  • Cancer Research 563
  • Hematology 99
  • Oncology 95
  • Immunology 80
Replace Roy Blum with:
Roy Blum United States
Vito D’Agostino Italy
Andrea Knau Germany
Matthew Knabel United States
Amaia Vilas‐Zornoza Spain
Yuan Xiao Zhu United States
Alper Yetil United States
Matteo Rossi Italy
Sébastien Grosso relative to Roy Blum United States Roy Blum's profile →
Citations per field
00.5×2.5×
Roy Blum · 1×
Citations per year

Countries citing papers authored by Sébastien Grosso

Since Specialization
Citations

This map shows the geographic impact of Sébastien Grosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Grosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Grosso more than expected).

Fields of papers citing papers by Sébastien Grosso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Grosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Grosso. The network helps show where Sébastien Grosso may publish in the future.

Co-authorship network of co-authors of Sébastien Grosso

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Grosso. A scholar is included among the top collaborators of Sébastien Grosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Grosso. Sébastien Grosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 192
2 31
3 35
4 26
5 348
6 67
7 20
8 15
9 31
10 58
11 58
12 52
13 32
14 40
15
[Fluoxetine versus fluvoxamine for treatment of chronic pain].
9

About Sébastien Grosso

Sébastien Grosso is a scholar working on Cancer Research, Hematology and Genetics, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (563 citations), Molecular Biology (719 citations) and Hematology (99 citations). Sébastien Grosso has collaborated with scholars based in France, United States and Denmark. Frequent co-authors include Bernard Mari, Pascal Barbry, Patrick Auberger, Bruno Cardinaud, Nathalie M. Mazure, Thomas Bertero, Pierre Gounon, Kévin Lebrigand, Alexandre Puissant and Pascal Colosetti. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026